University of Michigan Surgical Oncology Research Training Program

摘要 密歇根大学外科肿瘤学研究培训计划 有一个迫切需要外科肿瘤学家接受培训的研究学科。这次手术的目的 肿瘤学研究培训计划是为了促进生产力和成功的医生的发展 科学家Weiping Zou，医学博士，哲学博士、查尔斯B。de Nancrede病理学、免疫学、生物学教授， 外科医生和杰奎琳·杰鲁斯医学博士哲学博士、外科、病理学和生物医学工程教授 担任该计划的副主任。受训者将是参加两年奖学金的外科住院医生。 奖学金的具体目标是：1）设计，实施，分析和报告研究项目; 2）获得 基础研究方法和临床研究/试验指导; 3）获得基础研究指导 癌症生物学和免疫学，以及卫生服务研究原理。 密歇根大学罗格癌症中心提供了广泛的癌症相关研究 实验室和培训计划。Rogel癌症中心是一家NCI指定的癌症中心， 是美国国立卫生研究院研究资金最多的7个癌症中心之一。本培训计划中的所有导师 都是罗格癌症中心的成员该计划得益于该部的良好记录 吸引学术导向的外科住院医生。每位学员将被分配一名导师， 在项目期间开展研究项目。该计划的课程包括广泛的教学重点 基本的癌症生物学和免疫学原理，以及针对学术指导 职业发展。在负责任的研究行为的正式指示是必需的，并通过提供 大学。由国际知名癌症临床护理专家组成的外部咨询委员会， 为这一重要计划开展研究提供指导和支持。 这一培训方案已经存在了六个供资期，时间跨度为30年。程序继续 该项目非常成功，从未出现空缺，已招收了61名学员。在受训人员中， 来自代表性不足的少数民族群体的人占36%，女性占36%。根据2020年的一项研究， Demblowski等人发现，截至2020年6月，只有0.7%的外科医生科学家持有NIH R基金。 最近对以前受训人员的调查显示，47%的受访者接受了外部资助，89%的受访者报告说， 参与临床试验研究。在45名完成T32研究金课程的学员中， 临床培训，87%受雇于学术/教学医院。Narahari等人建议， NIH为外科医生-科学家提供更多的早期职业支持，以协助外科医生-科学家的职业生涯规划。 这个T32计划在满足年轻外科医生准备这一关键目标方面非常成功， 非常成功的外科学术生涯

Abstract University of Michigan Surgical Oncology Research Training Program There is a critical need for surgical oncologists to be trained in research disciplines. The purpose of this surgical oncology research training program is to foster the development of productive and successful physician scientists. Weiping Zou, M.D., Ph.D., the Charles B. de Nancrede Professor of Pathology, Immunology, Biology, and Surgery and Jacqueline Jeruss, M.D., Ph.D., Professor of Surgery, Pathology, and Biomedical Engineering serve as Co-Directors of this program. Trainees will be surgical residents enrolled in a two-year fellowship. Specific aims of the fellowship are: 1) design, implement, analyze and report a research project; 2) obtain instruction on fundamental research methods and clinical studies/trials; and 3) obtain instruction on fundamental cancer biology and immunology, and health services research principles. The University of Michigan Rogel Cancer Center provides an extensive breadth of cancer-related research laboratories and programs to the trainees. The Rogel Cancer Center is an NCI-designated Cancer Center that is among the top 7 cancer centers in terms of NIH research funding. All preceptors within this training program are members of the Rogel Cancer Center. This program benefits from the strong track record of the Department of Surgery in attracting academically oriented surgical residents. Each trainee will be assigned a mentor(s) to implement a research project during the program. The program curriculum includes extensive instruction focused on fundamental cancer biology and immunology principles, as well as instruction directed towards academic career development. Formal instruction in the responsible conduct of research is required and provided through the University. An External Advisory Committee of internationally renowned experts in clinical cancer care and research has been enlisted to provide guidance and support for this important program. This training program has been in existence for six funding periods spanning 30 years. The program continues to be highly successful and has never gone unfilled, having enrolled 61 trainees. Of the trainees, 18% were individuals from underrepresented minority ethnic groups, and 36% were female. According to a 2020 study, Demblowski et al. found that, as of June 2020, only 0.7% of surgeon scientists held NIH R grant funding.1 A recent survey of prior trainees revealed that 47% of respondents received external funding and 89% reported involvement in clinical trials research. Among the 45 trainees who completed the T32 fellowship and their formal clinical training, 87% are employed at academic/teaching hospitals. Narahari et al. suggest institutions and the NIH provide increased early-career support to surgeon-scientists to assist surgeon-scientist career trajectories.2 This T32 program has been highly successful in meeting this critical objective of preparing young surgeons for highly successful academic surgical careers.